Cargando…

Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort study

BACKGROUND: The extent of contribution of disturbed magnesium balance to mortality remains unclear among hemodialysis patients. METHODS: This was a cohort study involving 3276 patients on maintenance hemodialysis at 86 facilities in Japan from 2008 to 2010 who had secondary hyperparathyroidism (SHPT...

Descripción completa

Detalles Bibliográficos
Autores principales: Kurita, Noriaki, Akizawa, Tadao, Fukagawa, Masafumi, Onishi, Yoshihiro, Kurokawa, Kiyoshi, Fukuhara, Shunichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655801/
https://www.ncbi.nlm.nih.gov/pubmed/26613035
http://dx.doi.org/10.1093/ckj/sfv097
_version_ 1782402222232961024
author Kurita, Noriaki
Akizawa, Tadao
Fukagawa, Masafumi
Onishi, Yoshihiro
Kurokawa, Kiyoshi
Fukuhara, Shunichi
author_facet Kurita, Noriaki
Akizawa, Tadao
Fukagawa, Masafumi
Onishi, Yoshihiro
Kurokawa, Kiyoshi
Fukuhara, Shunichi
author_sort Kurita, Noriaki
collection PubMed
description BACKGROUND: The extent of contribution of disturbed magnesium balance to mortality remains unclear among hemodialysis patients. METHODS: This was a cohort study involving 3276 patients on maintenance hemodialysis at 86 facilities in Japan from 2008 to 2010 who had secondary hyperparathyroidism (SHPT). Baseline serum magnesium (sMg) values were categorized into quintiles (≤2.3, >2.3–2.5, >2.5–2.7, >2.7–3.0 and >3.0 mg/dL), and the middle quintile was set as the reference. Outcome was all-cause death. Independent contribution to all-cause death was assessed via Cox regression to generate population-attributable fractions (PAFs). RESULTS: A total of 2165 patients from 68 facilities were analyzed. The lowest quintile of sMg was positively associated with lower serum potassium and albumin levels, higher C-reactive protein (CRP) levels and prevalence of atrial fibrillation and cerebrovascular disease than the other quintiles. The highest sMg quintile was positively associated with higher potassium levels, and negatively associated with lower serum albumin levels and higher intact parathyroid hormone and CRP levels and prevalence of cerebrovascular disease than the other quintiles. During a median follow-up of 3 years, the lowest and the second lowest quintiles of sMg were associated with all-cause death [adjusted hazard ratio (HR) 1.737, 95% confidence interval (95% CI) 1.200–2.512 and HR 1.675, 95% CI 1.254–2.238, respectively). Point estimates of adjusted HRs of the highest and the second highest sMg quintiles were higher than those of the middle quintile for all-cause death. Adjusted PAFs of lower sMg and of higher and lower sMg for all-cause death were 24.0% (95% CI 13.0–35.0%) and 30.7% (95% CI 14.5–46.8%), respectively. CONCLUSION: In hemodialysis patients with SHPT, dysregulated sMg is an important contributor to all-cause death. Further studies are warranted to examine whether or not correction of sMg improves survival.
format Online
Article
Text
id pubmed-4655801
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-46558012015-11-26 Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort study Kurita, Noriaki Akizawa, Tadao Fukagawa, Masafumi Onishi, Yoshihiro Kurokawa, Kiyoshi Fukuhara, Shunichi Clin Kidney J Contents BACKGROUND: The extent of contribution of disturbed magnesium balance to mortality remains unclear among hemodialysis patients. METHODS: This was a cohort study involving 3276 patients on maintenance hemodialysis at 86 facilities in Japan from 2008 to 2010 who had secondary hyperparathyroidism (SHPT). Baseline serum magnesium (sMg) values were categorized into quintiles (≤2.3, >2.3–2.5, >2.5–2.7, >2.7–3.0 and >3.0 mg/dL), and the middle quintile was set as the reference. Outcome was all-cause death. Independent contribution to all-cause death was assessed via Cox regression to generate population-attributable fractions (PAFs). RESULTS: A total of 2165 patients from 68 facilities were analyzed. The lowest quintile of sMg was positively associated with lower serum potassium and albumin levels, higher C-reactive protein (CRP) levels and prevalence of atrial fibrillation and cerebrovascular disease than the other quintiles. The highest sMg quintile was positively associated with higher potassium levels, and negatively associated with lower serum albumin levels and higher intact parathyroid hormone and CRP levels and prevalence of cerebrovascular disease than the other quintiles. During a median follow-up of 3 years, the lowest and the second lowest quintiles of sMg were associated with all-cause death [adjusted hazard ratio (HR) 1.737, 95% confidence interval (95% CI) 1.200–2.512 and HR 1.675, 95% CI 1.254–2.238, respectively). Point estimates of adjusted HRs of the highest and the second highest sMg quintiles were higher than those of the middle quintile for all-cause death. Adjusted PAFs of lower sMg and of higher and lower sMg for all-cause death were 24.0% (95% CI 13.0–35.0%) and 30.7% (95% CI 14.5–46.8%), respectively. CONCLUSION: In hemodialysis patients with SHPT, dysregulated sMg is an important contributor to all-cause death. Further studies are warranted to examine whether or not correction of sMg improves survival. Oxford University Press 2015-12 2015-11-20 /pmc/articles/PMC4655801/ /pubmed/26613035 http://dx.doi.org/10.1093/ckj/sfv097 Text en © The Author 2015. Published by Oxford University Press on behalf of ERA-EDTA. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Contents
Kurita, Noriaki
Akizawa, Tadao
Fukagawa, Masafumi
Onishi, Yoshihiro
Kurokawa, Kiyoshi
Fukuhara, Shunichi
Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort study
title Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort study
title_full Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort study
title_fullStr Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort study
title_full_unstemmed Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort study
title_short Contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort study
title_sort contribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort study
topic Contents
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655801/
https://www.ncbi.nlm.nih.gov/pubmed/26613035
http://dx.doi.org/10.1093/ckj/sfv097
work_keys_str_mv AT kuritanoriaki contributionofdysregulatedserummagnesiumtomortalityinhemodialysispatientswithsecondaryhyperparathyroidisma3yearcohortstudy
AT akizawatadao contributionofdysregulatedserummagnesiumtomortalityinhemodialysispatientswithsecondaryhyperparathyroidisma3yearcohortstudy
AT fukagawamasafumi contributionofdysregulatedserummagnesiumtomortalityinhemodialysispatientswithsecondaryhyperparathyroidisma3yearcohortstudy
AT onishiyoshihiro contributionofdysregulatedserummagnesiumtomortalityinhemodialysispatientswithsecondaryhyperparathyroidisma3yearcohortstudy
AT kurokawakiyoshi contributionofdysregulatedserummagnesiumtomortalityinhemodialysispatientswithsecondaryhyperparathyroidisma3yearcohortstudy
AT fukuharashunichi contributionofdysregulatedserummagnesiumtomortalityinhemodialysispatientswithsecondaryhyperparathyroidisma3yearcohortstudy